Hong Kong Team Finds Biodegradable Plastic in Trout Blood

Polylactic acid, or PLA, is one of the world’s most widely used substitutes for conventional plastic. It shows up in food packaging, agricultural film and medical implants, and it carries a reassuring label: biodegradable. A research team at City University of Hong Kong, led by Wang Wenxiong, has now published work suggesting that label may be too comfortable, after finding degraded PLA particles in the blood of rainbow trout.

The starting point is a distinction that is easy to blur. A material that breaks down is not necessarily a material that breaks down harmlessly. In the environment, PLA is exposed to sunlight, oxidation and water, and it fragments into ever smaller particles whose surface chemistry and physical properties change as they age. Those weathered particles are not the same object that was tested when the plastic was fresh.

Much of microplastic toxicology has focused on the organs that sit at the front line: the gut, the liver and the gills. Blood has received far less attention, even though it is the transport system that carries whatever is absorbed to the rest of the body. The Hong Kong team chose rainbow trout as its subject and looked specifically at the circulatory system, asking what happens once particles get past the intestinal wall.

The choice of fish is not incidental. Aquaculture and wild fisheries both sit downstream of everything that washes off land, and fish are exposed continuously rather than episodically. Rainbow trout are a well-studied laboratory species, which makes it easier to compare results across experiments.

What the work points toward is a rethinking of how degradable plastics are certified. If aging changes how a particle interacts with tissue, then safety assessments built on pristine material may be measuring the wrong thing. The same logic applies to the wider family of biodegradable and bio-based polymers now being scaled up as replacements.

For consumers, the practical takeaway is not to abandon alternatives to conventional plastic. It is that “biodegradable” describes what a material does, not what it leaves behind. The question researchers are now pressing is whether the fragments produced along the way are benign, inert or something else entirely.

The next step for this line of work is to establish whether the particles found in blood accumulate, clear, or provoke a response in the vessel walls, and whether the effect differs for weathered versus fresh material. Those are slow experiments, but they are the ones that would turn a warning into a regulatory standard. Until then, the finding stands as a caution: the substitute is not automatically the safe option.